You are here

  • Home
  • Archive
  • Volume 4, Issue 4
  • ‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

Article metrics

Article menu
Download PDFPDF
Original Articles
‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 2019200
Feb 20191402
Mar 20191101
Apr 2019700
May 2019600
Jun 2019900
Jul 2019800
Aug 2019600
Sep 20191000
Oct 20191500
Nov 2019300
Dec 2019600
Jan 20201600
Feb 2020400
Mar 2020200
Apr 2020200
May 20201800
Jun 20201400
Jul 20201202
Aug 2020400
Sep 20201300
Oct 2020800
Nov 2020800
Dec 2020400
Jan 2021600
Mar 20211800
Apr 2021400
May 2021200
Oct 2021800
Nov 2021600
Dec 2021800
Jan 20221200
Feb 20221200
Mar 20222000
Apr 20221400
May 20223600
Jun 20223600
Jul 20221801
Aug 20223200
Sep 20223600
Oct 20223000
Nov 20223000
Dec 20221000
Jan 20231200
Feb 20235600
Mar 2023600
Apr 20231000
May 2023600
Jun 2023400
Jul 20231100
Aug 2023200
Sep 20231600
Oct 2023400
Nov 20231200
Dec 20232000
Jan 20241200
Feb 20241600
Mar 2024400
Apr 20241800
Total74906